BSEBoard Meeting1d ago · 27 Oct 2026, 12:54 pm

Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve un-audited standalone and consolidated financial results for the quarter and half year ended 30.09.2026

Themis Medicare Ltd · 530199

✦ AI SummaryResults

Themis Medicare Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 05/11/2026 to consider and approve un-audited standalone and consolidated financial results for the quarter and half year ended 30.09.2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Themis Medicare Ltd - 530199 - Board Meeting Intimation for Consideration And Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30.09.2026

Attachments (1)

📄

444b6851-67f8-4883-93cd-7f238f621955.pdf

pdf

Download →
View document text
TML/BSE/NSE/2026-27/39 27th October, 2026 The Manager The Manager – Listing Department Corporate Relationship Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, Floor 25, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Dalal Street, Mumbai- 400001 Bandra (East), Mumbai- 400051 Scrip Code – 530199 Symbol: THEMISMED Dear Sir / Madam, Sub: Intimation of date of Board meeting of the Company under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of Themis Medicare Limited is scheduled to be held on Thursday, 05th November, 2026 to consider and approve the Standalone and Consolidated Un-Audited Financial Results for the quarter and half year ended on 30th September, 2026 and Limited Review Reports of the Statutory Auditors thereon; Further, we would like to inform you that as per the Company’s Code of Conduct for Prevention of Insider Trading pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company had intimated its ‘Designated Persons’ that the Trading Window would remain closed from 01st October, 2026 till the expiry of 48 hours from the date of publication of the said financial results of the Company. This is for your information and record please. Thanking you, Yours faithfully, For Themis Medicare Ltd Dr. Dinesh S. Patel Chairman DIN: 00033273 Themis Medicare Limited Corporate Office: 11/12 Udyog Nagar, S V Road, Goregaon (W), Mumbai – 400 104, India *Tel.: 91-22-67607080*Fax: 91-22-67607070/ 28746621 Regd. Office: Plot No. 69-A, G.I.D.C., Industrial Estate, Vapi-Gujarat CIN No.: L24110GJ1969PLC001590 *Tel/ Fax No.: Regd. Off.: 0260-2431447/ 2430219 *E-mail: themis@themismedicare.com*Website: www.themismedicare.com